Washington University School of Medicine in St. Louis and Caeli Vascular, Inc., are developing the first sequestered therapy device for removal of deep vein thrombosis.
$2 Million Grant to Develop Sequestered Vascular Surgery Technology
Tag: Pulmonary Embolism
WashU CT hosts Inaugural STL Shock Symposium
The St. Louis Shock Symposium aims to help attendees understand of the optimal treatments of cardiogenic shock and severe acute respiratory distress syndrome.